Cross-scale bioanalytical integration for decoding tumour regulatory plasticity in oncology

Area of Science:

• Oncology
• Bioanalytical Chemistry
• Computational Biology

Background:

• Cancer exhibits genetic variability and complex microenvironment interactions, challenging traditional diagnostic and therapeutic approaches.
• Bulk analytical methods lack the resolution to address cancer's intricate spatial, temporal, and functional dimensions.
• There is a critical need for advanced bioanalytical methods to unravel tumor complexity.

Purpose of the Study:

• To review emerging integrated bioanalytical technologies for high-resolution cancer profiling.
• To highlight applications in maintaining tissue architecture and monitoring disease dynamics.
• To discuss the role of these technologies in advancing precision oncology.

Main Methods:

• Single-cell transcriptomics and chromatin accessibility profiling for cellular diversity.
• Spatial transcriptomics and multiplexed imaging for tumor-immune ecosystem mapping.
• Mass spectrometry-based proteomics and metabolomics for functional insights.
• AI-enabled computational analysis for multi-omics integration and predictive modeling.

Main Results:

• These integrated technologies provide high-resolution molecular profiling and maintain tissue architecture.
• Single-cell and spatial omics reveal cellular diversity and spatial organization of tumor-immune interactions.
• Proteomic and metabolomic approaches offer insights into signaling networks and metabolic adaptations.
• AI frameworks facilitate multi-omics convergence, biomarker discovery, and predictive modeling.

Conclusions:

• Next-generation bioanalytical strategies integrating molecular, spatial, and temporal data are crucial for precision oncology.
• These approaches enable earlier cancer detection, adaptive therapies, and personalized management.
• Key challenges include cross-scale data integration, dynamic disease tracking, and developing clinically interpretable tools.